CHEK2

Gene

Related News

ESMO Guidelines Endorse Lutetium Therapy; New Data on PSMA Prediction, DOAC Safety

Jun 01, 2026

European guidelines now recommend lutetium-177 PSMA-617 for advanced prostate cancer, while a machine-learning model predicts treatment radiation dose. A study finds DOACs safe with modern prostate cancer drugs.

HRD Testing and Biomarker-Driven Maintenance Transform Advanced Ovarian Cancer Care

Feb 14, 2026

Homologous recombination deficiency testing and molecular profiling are reshaping treatment strategies for advanced ovarian cancer, guiding PARP inhibitor and bevacizumab maintenance decisions in newly diagnosed patients.